Indian pharma companies focus on innovative research in foreign countries through dedicated entities Read more
Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in India: GlobalData Read more
Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey Read more